Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations

被引:3
|
作者
Galvani, Francesca [1 ]
Pala, Daniele [2 ]
Cuzzolin, Alberto [2 ]
Scalvini, Laura [1 ]
Lodola, Alessio [1 ]
Mor, Marco [1 ,3 ]
Rizzi, Andrea [2 ]
机构
[1] Univ Parma, Dipartimento Sci Alimenti & Farmaco, I-43124 Parma, Italy
[2] Chiesi Farmaceut SpA, Chem Res & Drug Design Dept, I-43122 Parma, Italy
[3] Univ Parma, Microbiome Res Hub, I-43124 Parma, Italy
关键词
TARGET RESIDENCE TIME; DIARYL IMIDAZOLIDIN-2-ONE DERIVATIVES; ACCELERATED MOLECULAR-DYNAMICS; DISSOCIATION RATE; BINDING-KINETICS; DRUG; MECHANISM; DISCOVERY; DESIGN; SELECTIVITY;
D O I
10.1021/acs.jcim.3c00042
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The residence time (RT), the time for which a drug remains bound to its biological target, is a critical parameter for drug design. The prediction of this key kinetic property has been proven to be challenging and computationally demanding in the framework of atomistic simulations. In the present work, we setup and applied two distinct metadynamics protocols to estimate the RTs of muscarinic M3 receptor antagonists. In the first method, derived from the conformational flooding approach, the kinetics of unbinding is retrieved from a physics-based parameter known as the acceleration factor alpha (i.e., the running average over time of the potential deposited in the bound state). Such an approach is expected to recover the absolute RT value for a compound of interest. In the second method, known as the tMETA-D approach, a qualitative estimation of the RT is given by the time of simulation required to drive the ligand from the binding site to the solvent bulk. This approach has been developed to reproduce the change of experimental RTs for compounds targeting the same target. Our analysis shows that both computational protocols are able to rank compounds in agreement with their experimental RTs. Quantitative structure-kinetics relationship (SKR) models can be identified and employed to predict the impact of a chemical modification on the experimental RT once a calibration study has been performed.
引用
收藏
页码:2842 / 2856
页数:15
相关论文
共 50 条
  • [31] Sialorrhea Successfully Treated by the Combined Use of Selective M1 and M3 Muscarinic Acetylcholine Receptor Antagonists
    Yamamura, Yukie
    Nonaka, Manabu
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2019, 86 (02) : 117 - 121
  • [32] The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists
    Wang, Zhi-Peng
    Liu, Hui-Zhong
    Zhu, Liang
    Hu, You-Min
    Cui, Yong-Yao
    Niu, Yin-Yao
    Lu, Yang
    Chen, Hong-Zhuan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (05) : 1234 - 1239
  • [33] Effect of a muscarinic M3 receptor agonist on gastric motility
    Chiba, Toshimi
    Kudara, Norihiko
    Sato, Masaki
    Inomata, Masaaki
    Orii, Seishi
    Suzuki, Kazuyuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (11) : 2039 - 2041
  • [34] Discovery of a muscarinic M3 receptor selective antagonist.
    Ohtake, N
    Sagara, Y
    Kimura, T
    Fujikawa, T
    Hirose, H
    Hasegawa, T
    Noguchi, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U233 - U233
  • [36] Muscarinic receptor M3 activation promotes fibrocytes contraction
    Henrot, Pauline
    Eyraud, Edmee
    Maurat, Elise
    Point, Sophie
    Cardouat, Guillaume
    Quignard, Jean-Francois
    Esteves, Pauline
    Trian, Thomas
    Girodet, Pierre-Olivier
    Marthan, Roger
    Zysman, Maeva
    Berger, Patrick
    Dupin, Isabelle
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] The Role of Muscarinic Acetylcholine Receptor M3 in Cardiovascular Diseases
    Liu, Xinxing
    Yu, Yi
    Zhang, Haiying
    Zhang, Min
    Liu, Yan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [38] Roles of M3 muscarinic acetylcholine receptor on gastric functions
    Aihara, T
    Fujishita, T
    Okabe, S
    Matsui, M
    Taketo, M
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 101P - 101P
  • [39] Identification and molecular characterization of m3 muscarinic receptor dimers
    Zeng, FY
    Wess, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) : 19487 - 19497
  • [40] M3 muscarinic receptor expression on suburothelial interstitial cells
    Lamers, Wouter H.
    BJU INTERNATIONAL, 2009, 104 (10) : 1538 - 1538